Transformed Non-Hodgkin Lymphoma — Trials

Transformed Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

75 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 25
Ph III recruiting: 0
Growth YoY: —
Industry share: 2%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02628405	R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma	unknown	Phase 1 / Phase 2	30	Academic and Community Cancer Research UnitedOTHER	1	Jul 1, 2024	clinicaltrials
NCT04058470	Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma	unknown	Phase 1 / Phase 2	140	Huiqiang HuangOTHER	1	Apr 14, 2022	clinicaltrials